Neauvia is proud to announce that STIMULATE with Dual Core Technology has been awarded the prestigious Catalyst Award for “Most Disruptive Innovation” at the AMWC 2026 Awards in Monaco. This recognition marks another milestone for the brand, following its award-winning success at AMWC 2024 for “Best Injectable Dermal Filler”.
The AMWC Awards are internationally renowned for celebrating innovation and excellence in the global medical aesthetics market. With this distinction, STIMULATE is recognized as a true game changer – redefining the approach to aesthetic treatments.
At the heart of this innovation lies Dual Core Technology, that represents a new chapter in medical aesthetics – combining PEGDE-HA and CaHA to deliver results that go beyond correction toward true tissue regeneration.*
This award reflects years of research, scientific expertise, and a commitment to pushing boundaries. it reinforces Neauvia’s vision to rethink medical aesthetics and shape the future of regenerative treatments.
Legal mentions and references:
*Basso, M., Di Lella, E. and Marchetti, F. 2025. Dual Core: A Mechanical, Biological, and Metabolic Model for Physiological Bio-regeneration with PEG-Crosslinked Hyaluronic Acid Fillers. Journal of Applied Cosmetology. 43, 3 (Dec. 2025), 3–10. DOI:https://doi.org/10.56609/jac.v43i3.608.
Cavallini, M.; de Castro Isalguez, R.F.; Marchetti, F.; Kurbankadieva, I.R.; Vásquez, R.A.S.; Forjaz, D.P.; Zimbres, S.; Panithaporn, D. Physiological Bio-Regeneration in Aesthetic Medicine: A Conceptual Framework and Narrative Review of PEGDE-HA and CaHA-Based Formulations. Cosmetics 2026, 13, 67. https://doi.org/10.3390/cosmetics13020067.